Literature DB >> 24614212

Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.

Li Li1, Chuanyu Wei, Il-Kwon Kim, Yvonne Janssen-Heininger, Sudhiranjan Gupta.   

Abstract

Pulmonary arterial hypertension (PAH) is a devastating cardiopulmonary disorder with significant morbidity and mortality in patients with various lung and heart diseases. PAH is characterized by vascular obstruction which leads to a sustained increased pulmonary vascular resistance, vascular remodeling, and right ventricular hypertrophy and failure. Limited PAH therapies indicate that novel approaches are urgently needed for the treatment of PAH. Nuclear factor-κB (NF-κB) has been shown to play an important role in different cardiac pathologies; however, the role of NF-κB remains limited in the setting of PAH. Here, we investigated whether NF-κB inhibition in the lungs using Club (Clara) cell-10 promoter driving IκBα mutant had any effect in monocrotaline (MCT)-induced PAH mouse model. Our data revealed that MCT-induced PAH and right ventricular hypertrophy were associated with NF-κB activation, inflammatory response, and altered expression of bone morphogenetic protein receptor 2, inhibitor of differentiation, and Notch-3 signaling molecules in wild-type mice; and all these alterations were prevented in IκBα mutant mice treated with MCT. Moreover, endothelial cell apoptosis and endothelial-to-mesenchymal transition occurred in the lungs of MCT-treated wild-type mice and were restored in IκBα mutant+MCT mice, indicating an association with NF-κB signaling. In lung microvascular endothelial cells, IκBα (AA) mutant plasmid restored the decreased bone morphogenetic protein receptor 2 protein level and reversed the endothelial-to-mesenchymal transition process induced by transforming growth factor-β1. We conclude that NF-κB regulates bone morphogenetic protein receptor 2-inhibitor of differentiation-Notch-3 axis genes and the subsequent endothelial cell apoptosis and endothelial-to-mesenchymal transition events in the lungs, providing new mechanistic information about MCT-induced PAH and right ventricular hypertrophy.

Entities:  

Keywords:  NF-kappa B; hypertension, pulmonary; mice

Mesh:

Substances:

Year:  2014        PMID: 24614212     DOI: 10.1161/HYPERTENSIONAHA.114.03220

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  37 in total

Review 1.  Inflammasomes: a novel therapeutic target in pulmonary hypertension?

Authors:  Tara Elizabeth Scott; Barbara K Kemp-Harper; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2018-06-27       Impact factor: 8.739

2.  Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.

Authors:  Wen Tian; Xinguo Jiang; Yon K Sung; Eric Shuffle; Ting-Hsuan Wu; Peter N Kao; Allen B Tu; Peter Dorfmüller; Aiqin Cao; Lingli Wang; Gongyong Peng; Yesl Kim; Patrick Zhang; James Chappell; Shravani Pasupneti; Petra Dahms; Peter Maguire; Hassan Chaib; Roham Zamanian; Marc Peters-Golden; Michael P Snyder; Norbert F Voelkel; Marc Humbert; Marlene Rabinovitch; Mark R Nicolls
Journal:  Circulation       Date:  2019-08-29       Impact factor: 29.690

3.  Transcriptomic modifications in developmental cardiopulmonary adaptations to chronic hypoxia using a murine model of simulated high-altitude exposure.

Authors:  Sheila Krishnan; Robert S Stearman; Lily Zeng; Amanda Fisher; Elizabeth A Mickler; Brooke H Rodriguez; Edward R Simpson; Todd Cook; James E Slaven; Mircea Ivan; Mark W Geraci; Tim Lahm; Robert S Tepper
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-08       Impact factor: 5.464

Review 4.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

5.  Loss of lung WWOX expression causes neutrophilic inflammation.

Authors:  Sunit Singla; Jiwang Chen; Shruthi Sethuraman; Justin R Sysol; Amulya Gampa; Shuangping Zhao; Roberto F Machado
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-10       Impact factor: 5.464

Review 6.  Molecular Basis of Nitrative Stress in the Pathogenesis of Pulmonary Hypertension.

Authors:  Colin E Evans; You-Yang Zhao
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.

Authors:  Yu-Cai Chen; Tian-Yi Yuan; Hui-Fang Zhang; Dan-Shu Wang; Yu Yan; Zi-Ran Niu; Yi-Huang Lin; Lian-Hua Fang; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

8.  Endothelial-to-Mesenchymal Transition: An Evolving Paradigm and a Promising Therapeutic Target in PAH.

Authors:  Kurt R Stenmark; Maria Frid; Frédéric Perros
Journal:  Circulation       Date:  2016-04-04       Impact factor: 29.690

9.  Xinmai 'an extract enhances the efficacy of sildenafil in the treatment of pulmonary arterial hypertension via inhibiting MAPK signalling pathway.

Authors:  Yaolu Zhu; Yabin Sun; Shichang Zhang; Chuyuan Li; Yiwei Zhao; Boxin Zhao; Guofeng Li
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

10.  Cigarette Smoke and Nicotine-Containing Electronic-Cigarette Vapor Downregulate Lung WWOX Expression, Which Is Associated with Increased Severity of Murine Acute Respiratory Distress Syndrome.

Authors:  Zhenguo Zeng; Weiguo Chen; Alexander Moshensky; Zaid Shakir; Raheel Khan; Laura E Crotty Alexander; Lorraine B Ware; C M Aldaz; Jeffrey R Jacobson; Steven M Dudek; Viswanathan Natarajan; Roberto F Machado; Sunit Singla
Journal:  Am J Respir Cell Mol Biol       Date:  2021-01       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.